Short description
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Description
Remix Therapeutics is a biotechnology business that is working on developing small-molecule medicines to reprogram ribonucleic acid processing and cure disease in novel ways. The company's medicines aid in the identification of patterns in ribonucleic acid processing and their application to control gene expression in order to change the way genes are read from the genome, correcting, enhancing, or eliminating the gene message, allowing healthcare practitioners to address disease causes at their source.
Total funding
$$2020202
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess, Noaccessforu, Nopepepe, Noaccess, Uh Ohhhh, Uh Ohhhh, Noaccess, Noaccess, Noaccessforu
Sign in for full access
Founders
Kevin Bitterman, Peter Smith